| Financial Year |
March 31 2023 |
| Monetary Funds |
878,821,492.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
219,780,014.40 |
| Accounts Receivable |
421,744,566.76 |
| Advances to Suppliers |
5,020,163.10 |
| Other Receivables |
1,830,752.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
275,530,967.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,285,641.96 |
| Total Current Assets |
2,061,042,781.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
74,368,482.48 |
| Fixed Assetes |
1,273,168,083.83 |
| Under-construction Projects |
82,107,395.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,969,675.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
120,195.87 |
| Deferred Income Tax Assets |
62,716,538.23 |
| Other Non-Current Assets |
3,685,019.19 |
| Sub-Total of Non-Current Assets |
1,524,005,946.50 |
| Total Assets |
3,585,048,728.38 |
| Short-Term Loans |
659,150,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
777,165,706.76 |
| Accounts Payable |
333,125,047.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,637,820.35 |
| Taxes Payable |
3,118,643.93 |
| Interest Payable |
-- |
| Dividend Payable |
21,787,569.84 |
| Other payables |
24,931,055.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,792,517.07 |
| Other Current Liabilities |
82,786,646.42 |
| Sub-Total of Current Liabilities |
1,900,812,933.25 |
| Long-term Loans |
14,789,224.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
69,357,523.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
84,425,128.75 |
| Total Liabilities |
1,985,238,062.00 |
| Paid-In Capital(Or Share Stock) |
544,689,246.00 |
| Capital Surplus |
772,863,446.31 |
| Surplus Reserve |
46,441,014.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
235,816,959.88 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,599,810,666.38 |
| Owner's Equity（Stockholder's Equity） |
1,599,810,666.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,585,048,728.38 |
